BROWSE OUR programs
EPILEPTIC
DISORDERS
AED efficacy evaluation using predictive
EEG biomarkers and models of epilepsy
Parkinson’s
disease
Unlock the potential of your drug on prodromal,
late-onset phases of PD or on L-DOPA induced Dyskinesia
Latest News &Events
-
NEUROSCIENCE EVENTS IN PARIS, JULY 2022
-
SynapCell’s experts hit the West Coast road ! [June 2022]
-
EILAT XVI CONFERENCE ON NEW ANTIEPILEPTIC DRUGS & DEVICES
-
ADPD 2022: EEG Biomarkers used to evaluate Anti-Dyskinetic effect of drugs in Parkinson’s Disease
-
ASENT 2022
-
Synapcell and Reservoir Neuroscience announce collaboration for development of treatment for chronic epilepsy
-
AES 2021: Partnership with OVID Threapeutics in Epilepsy
-
CNS Therapeutics Xchange 2021
-
Society for Neuroscience 2021
-
IPEG 2021. A Virtual Event
-
BioJapan 2021 & more!
Let's talk about your next project

SynapCell
Bâtiment SYNERGY
ZAC ISIPARC
38330 Saint Ismier – France
Bâtiment SYNERGY
ZAC ISIPARC
38330 Saint Ismier – France
+33 (0) 458 171 583
OPEN INNOVATION
CAPABILITIES
SYNAPCELL 2019 © – All Rights Reserved